Association of smoking with phenotype at diagnosis and vascular interventions in patients with renal artery fibromuscular dysplasia

Hypertension

Volumn 61, Issue 6, 2013, Pages 1227-1232

  Savard, Sébastien ^a   Azarine, Arshid ^b   Jeunemaitre, Xavier ^c,d,e   Azizi, Michel ^d   Plouin, Pierre François ^a,d   Steichen, Olivier ^a,f,g  

^a Hypertension Unit   (France)

^b Department of Vascular Radiology ^*  (United States)

^c Centre for Rare Vascular Diseases   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^g HÔPITAL TENON   (France)

Author keywords

fibromuscular dysplasia; renal artery obstruction; renal hypertension; smoking

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE;

ADULT; AGE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ESSENTIAL HYPERTENSION; FEMALE; FIBROMUSCULAR DYSPLASIA; HUMAN; INFORMATION RETRIEVAL; KIDNEY ARTERY STENOSIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RENAL ARTERY; RENOVASCULAR HYPERTENSION; RETROSPECTIVE STUDY; RISK FACTOR; SEX; SMOKING; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE;

FIBROMUSCULAR DYSPLASIA; RENAL ARTERY OBSTRUCTION; RENAL HYPERTENSION; SMOKING;

ADULT; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FIBROMUSCULAR DYSPLASIA; FRANCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHENOTYPE; PROPORTIONAL HAZARDS MODELS; RENAL ARTERY OBSTRUCTION; RETROSPECTIVE STUDIES; SMOKING;

EID: 84878940896     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.00838     Document Type: Article

References (23)

1. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004; 350: 1862-1871.
2. Olin JW, Sealove BA. Diagnosis, management, and future developments of fibromuscular dysplasia. J Vasc Surg. 2011; 53: 826-836.e1.
3. Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X. Fibromuscular dysplasia. Orphanet J Rare Dis. 2007; 2: 28.
4. Mettinger KL, Ericson K. Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics. Stroke. 1982; 13: 46-52.
5. Pannier-Moreau I, Grimbert P, Fiquet-Kempf B, Vuagnat A, Jeunemaitre X, Corvol P, Plouin PF. Possible familial origin of multifocal renal artery fibromuscular dysplasia. J Hypertens. 1997; 15(12 pt 2): 1797-1801. (Pubitemid 28029684)
6. Perdu J, Boutouyrie P, Bourgain C, Stern N, Laloux B, Bozec E, Azizi M, Bonaiti-Pellié C, Plouin PF, Laurent S, Gimenez-Roqueplo AP, Jeunemaitre X. Inheritance of arterial lesions in renal fibromuscular dysplasia. J Hum Hypertens. 2007; 21: 393-400. (Pubitemid 46646173)
7. Rushton AR. The genetics of fibromuscular dysplasia. Arch Intern Med. 1980; 140: 233-236. (Pubitemid 10147667)
8. Lüscher TF, Keller HM, Imhof HG, Greminger P, Kuhlmann U, Largiadèr F, Schneider E, Schneider J, Vetter W. Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron. 1986; 44 suppl 1: 109-114.
9. Sang CN, Whelton PK, Hamper UM, Connolly M, Kadir S, White RI, Sanders R, Liang KY, Bias W. Etiologic factors in renovascular fibromuscular dysplasia. A case-control study. Hypertension. 1989; 14: 472-479. (Pubitemid 19270511)
10. Powell JT. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med. 1998; 3: 21-28. (Pubitemid 28267456)
11. Bofinger A, Hawley C, Fisher P, Daunt N, Stowasser M, Gordon R. Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers. J Hum Hypertens. 1999; 13: 517-520. (Pubitemid 29386839)
12. Mackay A, Brown JJ, Cumming AM, Isles C, Lever AF, Robertson JI. Smoking and renal artery stenosis. Br Med J. 1979; 2: 770. (Pubitemid 10231342)
13. Nicholson JP, Teichman SL, Alderman MH, Sos TA, Pickering TG, Laragh JH. Cigarette smoking and renovascular hypertension. Lancet. 1983; 2: 765-766. (Pubitemid 13003946)
14. Savard S, Steichen O, Azarine A, Azizi M, Jeunemaitre X, Plouin PF. Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics. Circulation. 2012; 126: 3062-3069.
15. Persu A, Touzé E, Mousseaux E, Barral X, Joffre F, Plouin PF. Diagnosis and management of fibromuscular dysplasia: An expert consensus. Eur J Clin Invest. 2012; 42: 338-347.
16. Stanley JC. Renal artery fibrodysplasia. In: Novick AC, Scable J, Hamilton G, eds. Renal Vascular Disease. London, UK: WB Saunders; 1996: 21-23.
17. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31-41.
18. Earley A, Miskulin D, Lamb EJ, Levey AS, Uhlig K. Estimating equations for glomerular filtration rate in the era of creatinine standardization: A systematic review. Ann Intern Med. 2012; 156: 785-95, W.
19. Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, Jaff MR, Kim ES, Mace P, Matsumoto AH, McBane RD, Kline-Rogers E, White CJ, Gornik HL. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation. 2012; 125: 3182-3190.
20. Boutouyrie P, Gimenez-Roqueplo AP, Fine E, Laloux B, Fiquet-Kempf B, Plouin PF, Jeunemaitre X, Laurent S. Evidence for carotid and radial artery wall subclinical lesions in renal fibromuscular dysplasia. J Hypertens. 2003; 21: 2287-2295. (Pubitemid 38293568)
21. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002; 346: 1954-1962. (Pubitemid 34651355)
22. Jeunemaitre X, Chatellier G, Kreft-Jais C, Charru A, DeVries C, Plouin PF, Corvol P, Menard J. Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol. 1987; 60: 820-825. (Pubitemid 17163442)
23. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005; 45: 1243-1248. (Pubitemid 40523144)